1 Introduction Cancer persists as the second leading cause of global mortality, with epidemiological projections estimating 19.97 million new cases and 9.74 million deaths in 2024 ( Nutraceuticals have emerged as compelling candidates in translational oncology, leveraging their dual capacity to potentiate anticancer effects while mitigating treatment-related toxicity ( 2 O 2 )-mediated responses, including adenosine triphosphate (ATP) depletion, iron-regulated epigenetic reprogramming, anti-apoptotic protein B cell lymphoma 2 (Bcl-2) inhibition, Bax (Bcl-2 associated X protein, a well-known pro-apoptotic mediator) activation, mitochondrial hyperpolarization induction, the cleavage of poly (ADP-ribose) polymerase (PARP, a known apoptotic indicator) and caspases, mainly caspases 3 and 7 as well as targeting hypoxia-inducible factor-1 ( HIF- ) ( The therapeutic application of VC in oncology has been plagued by persistent controversies, particularly regarding dose-response relationships and administration route efficacy

Le paractamol est un xnobiotique, cest--dire une molcule trangre lorganisme, qui doit tre mtabolise par le foie pour tre limine aprs son action
It uses helium plasma plus radio-frequency to contract tissue like heated cellophane, with results developing over 6-9 months. While primarily designed for fat reduction rather than skin tightening, cryolipolysis (commonly known as CoolSculpting) can help reduce small fat pockets contributing to a lower abdominal bulge
Kleber, M
It is a rapidly growing disease that leads to a poor quality of life []
Individual Health Conditions People with certain health conditions, such as asthma, kidney or liver disease, need to exercise caution and consult a healthcare provider before undergoing glutathione infusions